GB:LLY3
Leverage Shares 3x Long Eli Lilly LLY ETP Securities
$78.17
ETFs Similar to GB:LLY3
Comparison Results
| Name | Price | Price Change | Price Target | Smart Score | Expense Ratio | Asset Under Management | Follow |
|---|---|---|---|---|---|---|---|
| GB:XZMUXtrackers MSCI USA ESG UCITS ETF Accum Shs -1C- USD | $82.03 | $98.93(20.60% Upside) | 0.15% | 8.99B | |||
| GB:XUHCXtrackers MSCI USA Health Care UCITS ETF | $75.25 | $81.64(8.50% Upside) | 0.13% | 1.53B | |||
| GB:WHCAiShares MSCI World Health Care Sector ESG UCITS ETF USD | GBP 498.88 | GBP 533.58(6.96% Upside) | 0.18% | 507.74M | |||
| GB:DOCTLegal & General UCITS ETF PLC - L&G Healthcare Breakthrough UCITS ETF AccumUSD | $18.68 | $22.72(21.67% Upside) | 0.49% | 374.99M | |||
| GB:HLTWMul Ly W Heal C Shs -C-USD- Capitalisation | $664.35 | $875.36(31.76% Upside) | 0.30% | 117.17M | |||
| GB:XDG3Xtrackers MSCI Global SDG 3 Good Health UCITS ETF | $43.18 | $46.91(8.63% Upside) | 0.35% | 30.97M | |||
| GB:BIOTL&G Pharma Breakthrough UCITS ETF | $15.40 | $19.81(28.60% Upside) | 0.49% | 24.59M | |||
| GB:3LAZGraniteShares 3x Long Astrazeneca Daily ETP | GBP 3,300.00 | ― | <0.01% | 2.01M | |||
| GB:3SAZGraniteShares 3x Short Astrazeneca Daily ETP | GBP 446.00 | ― | <0.01% | 401.85K | |||
| GB:SLLYLeverage Shares Public Limited Company LS -3X SHORT ELI LILLY ETP 2025-21.07.75 on Structured Instrument | GBP 82.25 | ― | 0.01% | 52.49K |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| GB:XZMU | Xtrackers MSCI USA ESG UCITS ETF Accum Shs -1C- USD | 82.03 | 8.48 | 11.53% | |
| GB:XUHC | Xtrackers MSCI USA Health Care UCITS ETF | 75.25 | 14.01 | 22.89% | |
| GB:WHCA | iShares MSCI World Health Care Sector ESG UCITS ETF USD | 498.88 | 80.00 | 19.10% | |
| GB:DOCT | Legal & General UCITS ETF PLC - L&G Healthcare Breakthrough UCITS ETF AccumUSD | 18.68 | 4.77 | 34.29% | |
| GB:HLTW | Mul Ly W Heal C Shs -C-USD- Capitalisation | 664.35 | 111.15 | 20.09% | |
| GB:XDG3 | Xtrackers MSCI Global SDG 3 Good Health UCITS ETF | 43.18 | 5.92 | 15.88% | |
| GB:BIOT | L&G Pharma Breakthrough UCITS ETF | 15.40 | 1.64 | 11.95% | |
| GB:3LAZ | GraniteShares 3x Long Astrazeneca Daily ETP | 3300.00 | -710.00 | -17.71% | |
| GB:3SAZ | GraniteShares 3x Short Astrazeneca Daily ETP | 446.00 | -274.63 | -38.11% | |
| GB:SLLY | Leverage Shares Public Limited Company LS -3X SHORT ELI LILLY ETP 2025-21.07.75 on Structured Instrument | 82.25 | -437.38 | -84.17% |
ETFs Similar to GB:LLY3 FAQ
What is the cheapest alternative to GB:LLY3?
Among the ETFs similar to GB:LLY3, GB:3LAZ (GraniteShares 3x Long Astrazeneca Daily ETP) has the lowest expense ratio, at 0.01% a year, compared with 0.01% for GB:LLY3.
GB:LLY3 vs. GB:XZMU: what is the difference?
GB:XZMU (Xtrackers MSCI USA ESG UCITS ETF Accum Shs -1C- USD) is the first ETF in GB:LLY3's similar-ETF list. It has $8.99B in assets under management and a 0.15% expense ratio, against $981.25K and 0.01% for GB:LLY3. Compare their performance, price targets and Smart Scores in the table above.
How is GB:LLY3 different from GB:SLLY?
GB:SLLY (Leverage Shares Public Limited Company LS -3X SHORT ELI LILLY ETP 2025-21.07.75 on Structured Instrument) comes from the same fund family as GB:LLY3 (Leverage Shares). GB:SLLY charges 0.01% a year, against 0.01% for GB:LLY3. GB:SLLY manages $52.49K in assets, against $981.25K for GB:LLY3. Both funds are in the comparison table above.

